Literature DB >> 20236181

Tumor growth suppression in vivo by overexpression of the circadian component, PER2.

Koyomi Miyazaki1, Miyuki Wakabayashi, Yasuhiro Hara, Norio Ishida.   

Abstract

Some reports have indicated that the core clock gene, Per2 regulates the cell cycle, immune system and neural functions. To understand the effects of PER2 on tumor growth in vivo, stable transformants of murine sarcoma 180 (S-180) cell lines expressing different levels of PER2 were established. The growth of stable PER2 transformants in vivo was significantly and dose-dependently suppressed according to the amount of PER2 expressed, indicating that PER2 plays a role in the growth suppression of sarcoma cells. The anchorage-dependent and -independent growth in vitro and expression of the clock controlled cell-cycle related genes, wee1, myc, and VEGF were not altered in stable PER2 transformants. In contrast, susceptibility to murine natural killer (NK) cell cytolytic activity was enhanced in PER2 transformants. Furthermore, PER2 transformants suppressed cell motility and reduced fibronectin expression, but the expression of integrin receptors was not affected. These results suggest that sarcoma cells overexpressing PER2 suppress tumors in vivo by changing the nature of tumor cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236181     DOI: 10.1111/j.1365-2443.2010.01384.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  31 in total

1.  Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats.

Authors:  Ryan W Logan; Changqing Zhang; Sengottuvelan Murugan; Stephanie O'Connell; Dale Levitt; Alan M Rosenwasser; Dipak K Sarkar
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

2.  PML regulates PER2 nuclear localization and circadian function.

Authors:  Takao Miki; Zhixiang Xu; Misty Chen-Goodspeed; Mingguang Liu; Anita Van Oort-Jansen; Michael A Rea; Zhaoyang Zhao; Cheng Chi Lee; Kun-Sang Chang
Journal:  EMBO J       Date:  2012-01-24       Impact factor: 11.598

3.  Nucleolar localization and circadian regulation of Per2S, a novel splicing variant of the Period 2 gene.

Authors:  Daniele Avitabile; Licia Genovese; Donatella Ponti; Danilo Ranieri; Salvatore Raffa; Antonella Calogero; Maria Rosaria Torrisi
Journal:  Cell Mol Life Sci       Date:  2013-11-08       Impact factor: 9.261

4.  Construction of a plasmid for overexpression of human circadian gene period2 and its biological activity in osteosarcoma cells.

Authors:  An-yuan Cheng; Yan Zhang; Hong-jun Mei; Shuo Fang; Peng Ji; Jian Yang; Ling Yu; Wei-chun Guo
Journal:  Tumour Biol       Date:  2015-01-07

5.  Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy.

Authors:  Wendy W Hwang-Verslues; Po-Hao Chang; Yung-Ming Jeng; Wen-Hung Kuo; Pei-Hsun Chiang; Yi-Cheng Chang; Tsung-Han Hsieh; Fang-Yi Su; Liu-Chen Lin; Serena Abbondante; Cheng-Yuan Yang; Huan-Ming Hsu; Jyh-Cherng Yu; King-Jen Chang; Jin-Yuh Shew; Eva Y-H P Lee; Wen-Hwa Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

6.  Circadian gene expression predicts patient response to neoadjuvant chemoradiation therapy for rectal cancer.

Authors:  Haijie Lu; Qiqi Chu; Guojiang Xie; Hao Han; Zheng Chen; Benhua Xu; Zhicao Yue
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 7.  Immunity's fourth dimension: approaching the circadian-immune connection.

Authors:  Alvaro Arjona; Adam C Silver; Wendy E Walker; Erol Fikrig
Journal:  Trends Immunol       Date:  2012-09-20       Impact factor: 16.687

8.  Altered circadian expression of cytokines and cytolytic factors in splenic natural killer cells of Per1(-/-) mutant mice.

Authors:  Ryan W Logan; Olivia Wynne; Dale Levitt; Debbi Price; Dipak K Sarkar
Journal:  J Interferon Cytokine Res       Date:  2013-02-12       Impact factor: 2.607

Review 9.  Running for time: circadian rhythms and melanoma.

Authors:  Elitza P Markova-Car; Davor Jurišić; Nataša Ilić; Sandra Kraljević Pavelić
Journal:  Tumour Biol       Date:  2014-04-14

Review 10.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.